Atossa Therapeutics (MEX:ATOS) Cyclically Adjusted FCF per Share: MXN-3,024.55 (As of Mar. 2026)


MEX:ATOS Atossa Therapeutics Inc MEX:ATOS
28 GF Score
Price MXN34.80
! 2 Warning Signs
View Full Analysis

What is Atossa Therapeutics Cyclically Adjusted FCF per Share?

Atossa Therapeutics MEX:ATOS +7.08% 28 Cyclically Adjusted FCF per Share is MXN-3,024.55 as of Mar. 2026. GuruFocus rates MEX:ATOS with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Atossa Therapeutics's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN-20.038. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN-3,024.55 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 33.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 23.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Atossa Therapeutics was 33.30% per year. The lowest was 7.90% per year. And the median was 17.50% per year.

As of today (2026-07-01), Atossa Therapeutics's current stock price is MXN34.80. Atossa Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN-3,024.55. Atossa Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Atossa Therapeutics  (MEX:ATOS) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Atossa Therapeutics Cyclically Adjusted FCF per Share Related Terms


Atossa Therapeutics Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Atossa Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atossa Therapeutics Cyclically Adjusted FCF per Share Chart

Atossa Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16,305.80 -13,837.11 -8,670.89 -8,594.63 -4,473.04

Atossa Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,780.63 -6,251.68 -4,570.09 -4,473.04 -3,024.55

MEX:ATOS vs QNCX, ZIVO, KTTA: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Atossa Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atossa Therapeutics Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atossa Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Atossa Therapeutics's Cyclically Adjusted Price-to-FCF falls into.


MEX:ATOS
28GF Score
Atossa Therapeutics Inc MEX:ATOS
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atossa Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Atossa Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-20.038/330.2130*330.2130
=-20.038

Current CPI (Mar. 2026) = 330.2130.

Atossa Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -2,191.500 241.018 -3,002.522
201609 722.235 241.428 987.836
201612 -1,331.286 241.432 -1,820.835
201703 -17,520.500 243.801 -23,730.407
201706 -580.595 244.955 -782.674
201709 -447.652 246.819 -598.902
201712 -186.740 246.524 -250.134
201803 -2,952.867 249.554 -3,907.271
201806 -175.698 251.989 -230.239
201809 -124.393 252.439 -162.717
201812 -129.179 251.233 -169.789
201903 -95.174 254.202 -123.633
201906 -79.048 256.143 -101.907
201909 -57.346 256.759 -73.752
201912 -83.864 256.974 -107.766
202003 -124.363 258.115 -159.101
202006 -83.931 257.797 -107.507
202009 -87.257 260.280 -110.702
202012 -61.173 260.474 -77.551
202103 -14.599 264.877 -18.200
202106 -13.108 271.696 -15.931
202109 -7.463 274.310 -8.984
202112 -8.899 278.802 -10.540
202203 -11.536 287.504 -13.250
202206 -14.177 296.311 -15.799
202209 -12.905 296.808 -14.357
202212 -10.464 296.797 -11.642
202303 -14.993 301.836 -16.403
202306 -9.068 305.109 -9.814
202309 -8.066 307.789 -8.654
202312 -11.321 306.746 -12.187
202403 -9.344 312.332 -9.879
202406 -9.910 314.175 -10.416
202409 -11.178 315.301 -11.707
202412 -17.421 315.605 -18.227
202503 -14.161 319.799 -14.622
202506 -15.873 322.561 -16.250
202509 -12.807 324.800 -13.020
202512 -22.052 324.054 -22.471
202603 -20.038 330.213 -20.038

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN-3,024.55 mean?
Atossa Therapeutics (MEX:ATOS) has a Cyclically Adjusted FCF per Share of MXN-3,024.55 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Atossa Therapeutics and its competitors.
Is Atossa Therapeutics' Cyclically Adjusted FCF per Share too high?
Atossa Therapeutics' current Cyclically Adjusted FCF per Share is MXN-3,024.55. Overall, Atossa Therapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Atossa Therapeutics' Cyclically Adjusted FCF per Share compare to QNCX and ZIVO?
Atossa Therapeutics' Cyclically Adjusted FCF per Share of MXN-3,024.55 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Atossa Therapeutics and its competitors. Atossa Therapeutics's current Cyclically Adjusted FCF per Share is MXN-3,024.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atossa Therapeutics stock overvalued right now?
Atossa Therapeutics (MEX:ATOS) has a current Cyclically Adjusted FCF per Share of MXN-3,024.55. The current Cyclically Adjusted FCF per Share is MXN-3,024.55. Atossa Therapeutics' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Atossa Therapeutics (MEX:ATOS), the current Cyclically Adjusted FCF per Share is MXN-3,024.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atossa Therapeutics Business Description

Other Exchanges ATOS:USAYAG:Germany
Address 1448 NW Market Street, Suite 500, Seattle, WA, USA, 98107
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
28GF Score

Get the complete analysis for MEX:ATOS

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN34.80
Price